Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomes

Author: Schuetz Philipp   Mueller Beat  

Publisher: Springer Publishing Company

ISSN: 0342-4642

Source: Intensive Care Medicine, Vol.40, Iss.1, 2014-01, pp. : 141-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content